期刊: BRITISH JOURNAL OF HAEMATOLOGY, 2022; 196 (1)
With the focus of leukaemia management shifting to the implications of low-level disease burden, increasing attention is being paid on the development......
期刊: BRITISH JOURNAL OF HAEMATOLOGY, 2022; 196 (2)
Historically, understanding of the human mast cell (MC) compartment has lagged behind the appreciation of other cell lineages. MCs exist in vascularis......
期刊: BRITISH JOURNAL OF HAEMATOLOGY, 2022; 196 (2)
High-sensitivity multicolour flow cytometry (MFC)-based B-lymphoblastic leukaemia (B-ALL) measurable residual disease (BMRD) assay is increasingly bei......
期刊: BRITISH JOURNAL OF HAEMATOLOGY, 2022; 196 (2)
In patients with beta-thalassaemia intermedia or major, hepcidin induces iron overload by continuously promoting iron absorption. There have been no s......
期刊: BRITISH JOURNAL OF HAEMATOLOGY, 2022; 196 (3)
Survival disparities by locus of care (LOC; paediatric versus adult) among adolescents and young adults (AYA) with acute lymphoblastic leukaemia (ALL)......
期刊: BRITISH JOURNAL OF HAEMATOLOGY, 2022; 196 (1)
Hydroxyurea (hydroxycarbamide) (HU) for sickle cell anaemia (SCA) is underutilised. Case management is an evidence-based health management strategy an......